S&P 500   4,327.42 (-0.06%)
DOW   34,018.21 (-0.15%)
QQQ   358.33 (+0.13%)
AAPL   175.27 (+0.77%)
MSFT   317.04 (-0.78%)
META   299.79 (+1.37%)
GOOGL   130.28 (-0.12%)
AMZN   128.84 (-0.38%)
TSLA   246.33 (-3.66%)
NVDA   413.80 (+0.88%)
NIO   8.47 (+0.24%)
BABA   88.06 (+4.70%)
AMD   95.81 (-0.31%)
T   15.21 (-0.65%)
F   12.49 (+2.38%)
MU   68.94 (+1.53%)
CGC   0.82 (+6.36%)
GE   111.97 (-0.90%)
DIS   81.69 (-1.26%)
AMC   7.74 (+0.52%)
PFE   32.61 (-0.73%)
PYPL   57.94 (-1.16%)
NFLX   378.95 (-1.35%)
S&P 500   4,327.42 (-0.06%)
DOW   34,018.21 (-0.15%)
QQQ   358.33 (+0.13%)
AAPL   175.27 (+0.77%)
MSFT   317.04 (-0.78%)
META   299.79 (+1.37%)
GOOGL   130.28 (-0.12%)
AMZN   128.84 (-0.38%)
TSLA   246.33 (-3.66%)
NVDA   413.80 (+0.88%)
NIO   8.47 (+0.24%)
BABA   88.06 (+4.70%)
AMD   95.81 (-0.31%)
T   15.21 (-0.65%)
F   12.49 (+2.38%)
MU   68.94 (+1.53%)
CGC   0.82 (+6.36%)
GE   111.97 (-0.90%)
DIS   81.69 (-1.26%)
AMC   7.74 (+0.52%)
PFE   32.61 (-0.73%)
PYPL   57.94 (-1.16%)
NFLX   378.95 (-1.35%)
S&P 500   4,327.42 (-0.06%)
DOW   34,018.21 (-0.15%)
QQQ   358.33 (+0.13%)
AAPL   175.27 (+0.77%)
MSFT   317.04 (-0.78%)
META   299.79 (+1.37%)
GOOGL   130.28 (-0.12%)
AMZN   128.84 (-0.38%)
TSLA   246.33 (-3.66%)
NVDA   413.80 (+0.88%)
NIO   8.47 (+0.24%)
BABA   88.06 (+4.70%)
AMD   95.81 (-0.31%)
T   15.21 (-0.65%)
F   12.49 (+2.38%)
MU   68.94 (+1.53%)
CGC   0.82 (+6.36%)
GE   111.97 (-0.90%)
DIS   81.69 (-1.26%)
AMC   7.74 (+0.52%)
PFE   32.61 (-0.73%)
PYPL   57.94 (-1.16%)
NFLX   378.95 (-1.35%)
S&P 500   4,327.42 (-0.06%)
DOW   34,018.21 (-0.15%)
QQQ   358.33 (+0.13%)
AAPL   175.27 (+0.77%)
MSFT   317.04 (-0.78%)
META   299.79 (+1.37%)
GOOGL   130.28 (-0.12%)
AMZN   128.84 (-0.38%)
TSLA   246.33 (-3.66%)
NVDA   413.80 (+0.88%)
NIO   8.47 (+0.24%)
BABA   88.06 (+4.70%)
AMD   95.81 (-0.31%)
T   15.21 (-0.65%)
F   12.49 (+2.38%)
MU   68.94 (+1.53%)
CGC   0.82 (+6.36%)
GE   111.97 (-0.90%)
DIS   81.69 (-1.26%)
AMC   7.74 (+0.52%)
PFE   32.61 (-0.73%)
PYPL   57.94 (-1.16%)
NFLX   378.95 (-1.35%)
NASDAQ:SILK

Silk Road Medical (SILK) Stock Forecast, Price & News

$15.81
+0.13 (+0.83%)
(As of 02:21 PM ET)
Compare
Today's Range
$15.30
$16.14
50-Day Range
$15.68
$23.15
52-Week Range
$15.03
$58.04
Volume
230,065 shs
Average Volume
663,731 shs
Market Capitalization
$613.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.60

Silk Road Medical MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
137.7% Upside
$37.60 Price Target
Short Interest
Healthy
3.94% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.56mentions of Silk Road Medical in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$210,404 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.46) to ($1.36) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Medical Sector

129th out of 968 stocks

Surgical & Medical Instruments Industry

19th out of 90 stocks


SILK stock logo

About Silk Road Medical (NASDAQ:SILK) Stock

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK Price History

SILK Stock News Headlines

Silk Road Medical, Inc: Downgrading to HOLD from BUY
Space CEO Featured on Good Morning America
A $25 Billion Earth Observation Market by 2040. Learn more
Analyst Expectations for Silk Road Medical's Future
Space CEO Featured on Good Morning America
A $25 Billion Earth Observation Market by 2040. Learn more
Q2 2023 Silk Road Medical Inc Earnings Call
B.Riley Financial Reaffirms Their Buy Rating on CareCloud (CCLD)
Silk Road Medical (NASDAQ: SILK)
SILK - Silk Road Medical, Inc
Why Silk Road Medical Stock Is Plunging Today
See More Headlines
Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Company Calendar

Last Earnings
8/01/2023
Today
9/22/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
Employees
414
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$37.60
High Stock Price Forecast
$55.00
Low Stock Price Forecast
$13.00
Forecasted Upside/Downside
+139.8%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
9 Analysts

Profitability

Net Income
$-55,010,000.00
Pretax Margin
-32.47%

Debt

Sales & Book Value

Annual Sales
$138.64 million
Book Value
$4.30 per share

Miscellaneous

Free Float
36,231,000
Market Cap
$608.85 million
Optionable
Not Optionable
Beta
1.16
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Ms. Erica J. RogersMs. Erica J. Rogers (Age 60)
    Pres, CEO & Director
    Comp: $1.17M
  • Mr. Lucas W. BuchananMr. Lucas W. Buchanan (Age 45)
    CFO & COO
    Comp: $870.55k
  • Mr. Kevin M. Klemz (Age 62)
    EVP, Chief Legal Officer & Sec.
    Comp: $644.12k
  • Mr. Andrew S. DavisMr. Andrew S. Davis (Age 54)
    Chief Commercial Officer
    Comp: $836.33k
  • Mr. Richard M. RuedyMr. Richard M. Ruedy (Age 56)
    Exec. VP of Clinical, Regulatory Affairs & Quality Assurance
    Comp: $542.41k
  • Ms. Mhairi L. Jones (Age 52)
    Chief Accounting Officer & VP of Fin.
  • Ms. Tammy Leitsinger
    Compliance Officer & VP of Medical Affairs
  • Mr. Matthew McCarthy
    VP of Marketing
  • Ms. Alison Highlander
    VP of HR
  • Dr. Sumaira MacDonald M.D.
    Ph.D., Exec. Medical Director













SILK Stock - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings
or view top-rated stocks.

What is Silk Road Medical's stock price forecast for 2023?

9 brokerages have issued 1-year price targets for Silk Road Medical's stock. Their SILK share price forecasts range from $13.00 to $55.00. On average, they expect the company's stock price to reach $37.60 in the next twelve months. This suggests a possible upside of 139.8% from the stock's current price.
View analysts price targets for SILK
or view top-rated stocks among Wall Street analysts.

How have SILK shares performed in 2023?

Silk Road Medical's stock was trading at $52.85 on January 1st, 2023. Since then, SILK stock has decreased by 70.3% and is now trading at $15.68.
View the best growth stocks for 2023 here
.

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our SILK earnings forecast
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings data on Tuesday, August, 1st. The company reported ($0.35) EPS for the quarter, topping analysts' consensus estimates of ($0.39) by $0.04. The company earned $45.30 million during the quarter, compared to analyst estimates of $43.32 million. Silk Road Medical had a negative net margin of 32.83% and a negative trailing twelve-month return on equity of 40.05%.

What ETFs hold Silk Road Medical's stock?

ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include American CenturyFocused Dynamic Growth ETF (FDG).iShares U.S. Medical Devices ETF (IHI).

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $180.00 million-$184.00 million, compared to the consensus revenue estimate of $179.54 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Bank Julius Baer & Co. Ltd Zurich (49.17%), Wasatch Advisors LP (13.55%), BlackRock Inc. (7.64%), Alliancebernstein L.P. (6.42%), Clearbridge Investments LLC (4.47%) and Bellevue Group AG (3.49%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Kevin M Klemz, Lucas W Buchanan, Richard Ruedy and Tony M Chou.
View institutional ownership trends
.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $15.68.

How much money does Silk Road Medical make?

Silk Road Medical (NASDAQ:SILK) has a market capitalization of $608.85 million and generates $138.64 million in revenue each year. The company earns $-55,010,000.00 in net income (profit) each year or ($1.41) on an earnings per share basis.

How many employees does Silk Road Medical have?

The company employs 414 workers across the globe.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -